Merck's own corporate history of the Mectizan Donation Program, dated 25 May 2022, stating the 1987 donation commitment and the later 1998 extension to lymphatic filariasis.
In 1987, Merck committed to donate Mectizan – as much as needed, for as long as needed – with the goal to help eliminate river blindness.
Merck's own corporate history of the Mectizan Donation Program, dated 25 May 2022, stating the 1987 donation commitment and the later 1998 extension to lymphatic filariasis. Company-authored page (self-interested source, recorded neutrally). Corroborated by mectizan.org/history ('1987: (l-r) Merck researchers Dr. Ken Brown, Dr. Mohammed Aziz, and Dr. William Campbell at the announcement of the Merck donation') and by the 1987 NYT report (IVA-03). Merck also notes the 1998 expansion to lymphatic filariasis with GSK-donated albendazole. Also filed as IVB-32 (claims C1, C7). Study type: other.
